
Retractable Technologies RVP
$ 0.82
0.0%
Quarterly report 2025-Q3
added 11-14-2025
Retractable Technologies Cash Conversion Cycle 2011-2025 | RVP
Annual Cash Conversion Cycle Retractable Technologies
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 250 | 208 | 116 | 54.2 | 73.4 | 90 | 89.4 | 72.6 | 87.7 | 72 | 51.9 | 52.4 | 38.4 | 88.2 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 250 | 38.4 | 96.1 |
Quarterly Cash Conversion Cycle Retractable Technologies
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 250 | 201 | 245 | - | 222 | 345 | 346 | - | 344 | 282 | 220 | - | 106 | 161 | 64.5 | - | 20.1 | 15.1 | 27.1 | - | 29.8 | 143 | 140 | 76.5 | 79.8 | 95.9 | 105 | 88.7 | 73.5 | 96.7 | 92 | - | 60.7 | 81.9 | 92.8 | - | 75.4 | 86.2 | 101 | - | 55.9 | 79.9 | 79.3 | - | 41.1 | 65.6 | 70.5 | - | 44.4 | 57 | 51 | - | 34 | 36.8 | 70.2 | - | 90.6 | 92.5 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 346 | 15.1 | 114 |
Cash Conversion Cycle of other stocks in the Medical instruments industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
BioLife Solutions
BLFS
|
37.9 | $ 24.39 | - | $ 1.12 B | ||
|
Baxter International
BAX
|
262 | $ 19.15 | - | $ 9.77 B | ||
|
Becton, Dickinson and Company
BDX
|
110 | $ 200.89 | - | $ 57.8 B | ||
|
Harvard Bioscience
HBIO
|
208 | $ 0.74 | - | $ 31.4 M | ||
|
ICU Medical
ICUI
|
143 | $ 148.43 | 0.82 % | $ 3.62 B | ||
|
Luminex Corporation
LMNX
|
18.9 | - | - | $ 1.75 B | ||
|
iRhythm Technologies
IRTC
|
58.7 | $ 168.83 | -0.16 % | $ 5.27 B | ||
|
Repro Med Systems
KRMD
|
149 | $ 5.78 | - | $ 264 M | ||
|
Akers Biosciences, Inc.
AKER
|
95.3 | - | -9.52 % | $ 20.6 M | ||
|
LeMaitre Vascular
LMAT
|
28.7 | $ 84.0 | 0.77 % | $ 1.89 B | ||
|
Masimo Corporation
MASI
|
83.7 | $ 138.34 | -2.08 % | $ 7.37 B | ||
|
Ekso Bionics Holdings
EKSO
|
266 | $ 4.67 | - | $ 94.2 M | ||
|
Merit Medical Systems
MMSI
|
171 | $ 86.7 | - | $ 5.05 B | ||
|
Antares Pharma, Inc.
ATRS
|
204 | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
400 | - | -1.18 % | $ 3.4 B | ||
|
Hill-Rom Holdings, Inc.
HRC
|
11.9 | - | -0.05 % | $ 10.3 B | ||
|
OraSure Technologies
OSUR
|
167 | $ 2.49 | -3.11 % | $ 185 M | ||
|
Varian Medical Systems, Inc.
VAR
|
194 | - | -0.02 % | $ 16.3 B | ||
|
Alcon
ALC
|
134 | $ 78.8 | - | $ 40.4 B | ||
|
ResMed
RMD
|
167 | $ 252.27 | - | $ 36.8 B | ||
|
AtriCure
ATRC
|
185 | $ 42.38 | - | $ 1.99 B | ||
|
Atrion Corporation
ATRI
|
253 K | - | - | $ 810 M | ||
|
electroCore
ECOR
|
2.97 | $ 4.75 | -1.45 % | $ 26.2 K | ||
|
AngioDynamics
ANGO
|
124 | $ 13.14 | - | $ 537 M | ||
|
STAAR Surgical Company
STAA
|
26 | $ 24.13 | - | $ 1.19 B | ||
|
STERIS plc
STE
|
112 | $ 251.79 | - | $ 24.8 B | ||
|
Stereotaxis
STXS
|
212 | $ 2.37 | - | $ 191 M | ||
|
The Cooper Companies
COO
|
210 | $ 82.08 | -0.04 % | $ 16.3 B | ||
|
Glaukos Corporation
GKOS
|
170 | $ 108.88 | -0.02 % | $ 5.27 B | ||
|
Haemonetics Corporation
HAE
|
217 | $ 83.49 | - | $ 4.2 B | ||
|
InfuSystem Holdings
INFU
|
24.9 | $ 9.24 | - | $ 191 M | ||
|
Isoray
ISR
|
173 | - | 0.03 % | $ 108 M | ||
|
Utah Medical Products
UTMD
|
280 | $ 58.1 | - | $ 211 M | ||
|
Intuitive Surgical
ISRG
|
208 | $ 542.32 | - | $ 193 B | ||
|
DENTSPLY SIRONA
XRAY
|
63.9 | $ 11.57 | - | $ 2.35 B | ||
|
Microbot Medical
MBOT
|
-52.9 | $ 2.41 | - | $ 24.6 M | ||
|
Milestone Scientific
MLSS
|
545 | $ 0.39 | 1.22 % | $ 31.1 M | ||
|
Nephros
NEPH
|
161 | $ 5.02 | - | $ 52.1 M | ||
|
NeuroMetrix
NURO
|
357 | - | 5.05 % | $ 9.02 M | ||
|
Envista Holdings Corporation
NVST
|
79.4 | $ 21.97 | - | $ 3.78 B | ||
|
Pro-Dex
PDEX
|
193 | $ 43.38 | -0.42 % | $ 143 M | ||
|
Pulse Biosciences
PLSE
|
36.5 | $ 14.24 | - | $ 684 M | ||
|
Predictive Oncology
POAI
|
-241 | - | - | $ 32.4 M | ||
|
Repligen Corporation
RGEN
|
272 | $ 157.39 | - | $ 8.77 M | ||
|
Teleflex Incorporated
TFX
|
183 | $ 126.88 | - | $ 5.94 B | ||
|
West Pharmaceutical Services
WST
|
98.9 | $ 267.56 | - | $ 19.5 B |